BREAKING: $ABT confirms a $20B senior notes offering to fund the Exact Sciences acquisition 🚨💵 Pricing…
Filed with the SEC on · Summarized by InvestorsBot
BREAKING: $ABT confirms a $20B senior notes offering to fund the Exact Sciences acquisition 🚨💵 Pricing agreement signed with Morgan Stanley, Barclays, BofA & J.P. Morgan — closing expected Mar 9, 2026. #ABT #ExactSciences #Mergers #DebtRaise
ALERT: What this means — proceeds will pay the acquisition consideration, repay Exact’s debt and cover fees; material levered financing that could pressure credit metrics and move the stock ⚠️📈 $ABT #M&A #Leverage #Credit #ExactSciences
Confirmed: Structure — $1B floating (2029) + fixed notes across 2029–2066 (coupons ~3.70%–5.60%). Biggest tranches: $3.75B (2036 @4.65%) & $3.75B (2056 @5.50%). Prospectus filed Feb 25; closing Mar 9 📅🧾 $ABT #FixedIncome #Bonds #Debt
ALERT: Underwriters led by Morgan Stanley, Barclays, BofA & J.P. Morgan; customary reps/indemnities. Abbott may top up with cash or other borrowings (including commercial paper) for the deal — watch liquidity moves 🔁 $ABT #Underwriters #CorporateFinance #Mergers